Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Neurophysiological methods in evaliuation of neurorehabiltation in children].
Corrigendum to "Evolution of diagnostic criteria for multiple sclerosis" [Pol. J. Neurol. Neurosurg. 49 (5) (2015) 313-321].
A Case of Optic Neuritis Concomitant with Pituitary Tumor during Pregnancy.
Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.
Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis.
Synaptic Pathology in the Cerebellar Dentate Nucleus in Chronic Multiple Sclerosis.
The obesity-related pathology and Th17 cells.
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
The aged brain: genesis and fate of residual progenitor cells in the subventricular zone.
[Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
[Melatonin as an inducing factor for multiple sclerosis].
Resveratrol Defends Blood-brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis Mice.
Acute optic neuritis with diffusion restriction on MRI.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina Project.
Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?

Pages